Grace Medical Spa | |
6900 Brockton Ave Ste 200 Riverside CA 92506-3818 | |
(909) 664-4634 | |
Not Available |
Full Name | Grace Medical Spa |
---|---|
Speciality | Internal Medicine |
Location | 6900 Brockton Ave Ste 200, Riverside, California |
Authorized Official Name and Position | Phillip Alhir (COO) |
Authorized Official Contact | 9096644634 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Grace Medical Spa 6900 Brockton Ave Ste 200 Riverside CA 92506-3818 Ph: (909) 664-4634 | Grace Medical Spa 6900 Brockton Ave Ste 200 Riverside CA 92506-3818 Ph: (909) 664-4634 |
NPI Number | 1689357030 |
---|---|
Provider Enumeration Date | 08/11/2023 |
Last Update Date | 12/08/2023 |
Medicare PECOS PAC ID | 0446608087 |
---|---|
Medicare Enrollment ID | O20231121001188 |
News Archive
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.
In this Al Jazeera opinion piece, Stan Cox, a senior scientist at The Land Institute in Salina, Kansas, reports on a proposed Food Security Act in India and examines whether the measure could help solve the country's food insecurity.
Significant numbers of today's women and underrepresented minority chemists and chemical engineers say they were discouraged from pursuing a STEM career at some point in their lives, according to a new Bayer Corporation.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1689357030 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (* (Not Available)) | Primary |
Provider Name | Melanchton A Mangoba |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1376605717 PECOS PAC ID: 8224113139 Enrollment ID: I20080317000164 |
News Archive
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.
In this Al Jazeera opinion piece, Stan Cox, a senior scientist at The Land Institute in Salina, Kansas, reports on a proposed Food Security Act in India and examines whether the measure could help solve the country's food insecurity.
Significant numbers of today's women and underrepresented minority chemists and chemical engineers say they were discouraged from pursuing a STEM career at some point in their lives, according to a new Bayer Corporation.
› Verified 7 days ago
Provider Name | Mousa Matar |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1992116982 PECOS PAC ID: 2567737026 Enrollment ID: I20210907001912 |
News Archive
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.
In this Al Jazeera opinion piece, Stan Cox, a senior scientist at The Land Institute in Salina, Kansas, reports on a proposed Food Security Act in India and examines whether the measure could help solve the country's food insecurity.
Significant numbers of today's women and underrepresented minority chemists and chemical engineers say they were discouraged from pursuing a STEM career at some point in their lives, according to a new Bayer Corporation.
› Verified 7 days ago
News Archive
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Mordor Intelligence announces the publication of their research study titled "Saudi Arabia Diagnostic Imaging Equipment Market- Growth, Trends & Forecast (2014-2020)." The report is an in-depth analysis of the companies operating in the country, the current market scenario and the investment opportunities.
In this Al Jazeera opinion piece, Stan Cox, a senior scientist at The Land Institute in Salina, Kansas, reports on a proposed Food Security Act in India and examines whether the measure could help solve the country's food insecurity.
Significant numbers of today's women and underrepresented minority chemists and chemical engineers say they were discouraged from pursuing a STEM career at some point in their lives, according to a new Bayer Corporation.
› Verified 7 days ago
Innovative Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4500 Brockton Ave Ste 305, Riverside, CA 92501 Phone: 206-445-9978 Fax: 858-280-3279 | |
Pulmonary Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5790 Magnolia Ave, Suite 201, Riverside, CA 92506 Phone: 951-368-0427 Fax: 951-368-0429 | |
Lyn M Pintelon D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8990 Garfield St, Ste.6, Riverside, CA 92503 Phone: 951-358-0784 Fax: 951-354-7583 | |
Precision Spinal Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4224 Cedar Pine Ct, Riverside, CA 92505 Phone: 909-648-0377 | |
Parkview Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3722 Tibbetts St, Riverside, CA 92506 Phone: 951-784-3770 | |
Orangecrest Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4646 Brockton Ave Ste 203, Riverside, CA 92506 Phone: 951-774-2881 Fax: 951-774-2846 | |
Harmony Health Solutions Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Division St Ste 208, Riverside, CA 92506 Phone: 310-560-9292 |